Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease.

Our current results reconfirm and extend the conclusions of the previously published report that the Erlangen Score is a useful tool facilitating interpretation of a complex pattern of the CSF AD biomarkers.